China, India Seen As Trend-Setters In Emerging Market Pharma Growth
This article was originally published in PharmAsia News
Executive Summary
China is expected to be among the leaders of a growing trend of growth in the global pharmaceutical industry being led by the emerging markets. That realization has attracted the attention of multinational and domestic drug makers that seek to benefit from the new markets that include China and India as well as Mexico and Turkey. IMS China Health Market Research Consulting said in a report that China's pharmaceutical market should continue growing at the rate of 20 percent this year, although down from the 26 percent registered in 2008, thanks in part to new health care reforms. China's health minister said changes in the nation's health-insurance coverage of essential drugs has expanded to include a much larger portion of the population based on average urban income level. (Click here for more
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.